John Paul Johnson - Mar 1, 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Financial Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Mar 1, 2022
Transactions value $
-$123,574
Form type
4
Date filed
3/3/2022, 08:34 PM
Next filing
Mar 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +24K +17.53% $0.00 161K Mar 1, 2022 Direct F1, F2, F3
transaction EVH Class A Common Stock Tax liability -$124K -4.51K -2.8% $27.40 156K Mar 1, 2022 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.